For example, astragaloside IV (AS-IV) also can reduces podocyte apoptosis by activating the PPARγ-Klotho-FoxO1 signaling pathway to inhibit oxidative stress, thereby improving DKD (Xing et al. 2021). Here, FOXO1 is linked to diabetic kidney disease.